Report Library
All Reports
Heart Failure and Dyslipidemia Pulse Survey
September 21, 2012
We surveyed 25 (US) and 15 (EU) cardiologists to determine potential usage of drugs with the
following MOAs in specified patient populations:
PCSK9 Inhibitors Mineralcorticoid Receptor Antagonists Endopeptidase
Inhibitors Direct Renin Inhibitors
| Indications Covered: |
Chronic Heart Failure - Reduced Ejection Fraction (Chronic HFrEF)
Dyslipidemia / Hypercholesterolemia |